Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high-risk follicular lymphoma due to severe haematological and infectious toxicity.
Chan Yoon Y CheahLoretta J NastoupilPeter McLaughlinMichelle A FanaleSattva S NeelapuLuis E FayadFrederick B HagemeisterNathan H FowlerPublished in: British journal of haematology (2015)